Investors

Insider Transactions

Date Name Title Type Shares Traded Price Range
May 1, 2013 schleifer leonard s Officer Automatic Sell 100,000 225.01 - 250.06
Apr 12, 2013 mccorkle douglas s Officer Automatic Sell 3,129 205.82 - 214.10
Apr 11, 2013 mccorkle douglas s Officer Automatic Sell 2,746 204.57
Apr 11, 2013 mccorkle douglas s Officer Option Execute 5,875 30.63
Apr 4, 2013 vagelos p roy Officer Disposition (Non Open Market) 1,215 n/a
Apr 1, 2013 goldstein joseph l Director Automatic Sell 5,000 180.00
Apr 1, 2013 goldstein joseph l Director Option Execute 5,000 24.41
Mar 21, 2013 brown michael s Director Automatic Sell 15,000 172.61 - 174.13
Mar 21, 2013 brown michael s Director Option Execute 15,000 18.61
Mar 19, 2013 schleifer leonard s Officer Automatic Sell 3,655 175.02
Mar 13, 2013 schleifer leonard s Officer Automatic Sell 4,662 175.01
Mar 7, 2013 schleifer leonard s Officer Automatic Sell 3,534 175.13
Mar 6, 2013 schleifer leonard s Officer Automatic Sell 69,003 175.28 - 176.10
Mar 5, 2013 schleifer leonard s Officer Automatic Sell 19,146 175.21
Feb 26, 2013 shooter eric m Director Acquisition (Non Open Market) 10,000 n/a
Feb 26, 2013 shooter eric m Director Sell 10,000 160.00
Jan 16, 2013 goldberg murray a Officer Automatic Sell 7,878 170.57 - 174.56
Jan 9, 2013 goldstein joseph l Director Automatic Sell 5,000 185.00
Jan 9, 2013 goldstein joseph l Director Option Execute 5,000 57.11
Jan 9, 2013 powchik peter Officer Option Execute 5,752 16.80 - 21.25
Showing 181-200 of 773 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Regeneron Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.



Close
Form content here please :)